Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine–naloxone and standard medical management?

✍ Scribed by Weiss, Roger D.; Griffin, Margaret L.; Potter, Jennifer Sharpe; Dodd, Dorian R.; Dreifuss, Jessica A.; Connery, Hilary S.; Carroll, Kathleen M.

• Book ID: 123317159
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 515 KB
• Volume: 140
• Category: Article
• ISSN: 0376-8716
• DOI: 10.1016/j.drugalcdep.2014.04.005